In response to the ongoing COVID-19 (coronavirus) outbreak
internationally and in the U.S., Mayo Clinic remains committed to the
continued safety of our patients, staff, and community members.
Mayo Clinic’s response to COVID-19 includes activating a
multidisciplinary team of world experts in infectious diseases and Mayo
leaders who will continuously monitor the situation, meet with state and
federal emergency agencies, and oversee prevention and control actions
taken by Mayo Clinic.
We are also committed to providing you with trusted information on
COVID-19, including these sources:
* *Latest updates from Mayo Clinic experts.* Visit Mayo Clinic News
Network
<https://newsnetwork.mayoclinic.org/tag/covid-19/?elqTrackId=393c6cdfa07444f8906272bc1e5f3e8c&elq=737a51f09bc44573a368204fd10894da&elqaid=1332&elqat=1&elqCampaignId=631>
for a stream of articles updated in real time as circumstances and
guidance from public health agencies change.
* *Mayo Clinic’s real-time test for COVID-19.* Mayo Clinic
Laboratories has developed a test that can detect the SARS-CoV-2
(the cause of COVID-19) in clinical samples. The test has been fully
validated, and data will be submitted to the Food and Drug
Administration for review and emergency use authorization. More
information is available on the Mayo Clinic News Network
<https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-develops-test-to-detect-covid-19-infection/?elqTrackId=80876b10bc8841738191edb57f18de02&elq=737a51f09bc44573a368204fd10894da&elqaid=1332&elqat=1&elqCampaignId=631>
and the Star Tribune
<http://www.startribune.com/mayo-clinic-rolls-out-covid-19-test/568741482/?elqTrackId=2ed3e542893c425e850d7c995dfe5fdc&elq=737a51f09bc44573a368204fd10894da&elqaid=1332&elqat=1&elqCampaignId=631>.
* *Advancing a COVID-19 vaccine.* Mayo researchers in infectious
diseases are making significant progress to address emerging
pathogens including COVID-19 and related viruses. As one example,
Mayo experts are developing a vaccine using gene therapy technology
in a novel potent vaccine platform. The same innovative technology
can be successfully applied for vaccination against other dangerous
microorganisms such as influenza, HIV, Ebola, Zika, and /Clostridium
difficile/. Our active research in emerging pathogens also lays the
foundation for standard operating processes to address future
pandemics.
* *Offering drive-through specimen collection for pre-screened
patients in Rochester.* Mayo Clinic staff will collect the
specimens, using appropriate precautions, and send them to the
Minnesota Department of Health for analysis. This process reduces
the need for other critically constrained resources. Patients are
required to have a phone screening first to determine if testing is
appropriate. More information is available on the Mayo Clinic News
Network
<https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-offers-pre-screened-patients-drive-through-specimen-collection-for-covid-19-testing/?elqTrackId=b2f1b3c5ac214e46a4fff5de58984e2b&elq=737a51f09bc44573a368204fd10894da&elqaid=1332&elqat=1&elqCampaignId=631>.
Mayo Clinic is currently following CDC guidelines
<https://www.cdc.gov/coronavirus/2019-ncov/travelers/index.html?elqTrackId=e1d9b1147b564824ad2cd7f7d748da73&elq=737a51f09bc44573a368204fd10894da&elqaid=1332&elqat=1&elqCampaignId=631>
for patient travel and taking appropriate precautions to delay the
appointments of visitors from affected areas (those countries deemed
“Level 3” and “Level 2” in CDC’s risk assessment). Appointment access
for patients from other areas has not changed, but safety and screening
procedures have been put in place to identify anyone showing symptoms of
possible infection.
Your health is our primary concern. As the global leader in health care,
we are leveraging every resource at our disposal to respond to this
ever-changing situation. The most vital thing people can do is remain
informed and follow safety and prevention guidelines.
Together, we will address this challenge, and Mayo Clinic will remain a
place of hope and healing for our patients.
Thank you for your continued trust in Mayo Clinic,
Evanthia Galanis, M.D.
Executive Dean for Development
Mayo Clinic
_______________________________________
http://www.okiebenz.com
To search list archives http://www.okiebenz.com/archive/
To Unsubscribe or change delivery options go to:
http://mail.okiebenz.com/mailman/listinfo/mercedes_okiebenz.com
